Nateglinide Tablet
Product Images NDC 51407-656

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nateglinide (NDC 51407-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-656-01 (REV 09-22.jpg)

These are tablets with USP containing 60 mg Nateglinide. The container should be light-resistant as defined in USP, and it should be kept away from children. The tablets should be stored between 15°C to 30°C (59°F to 86°F) and the dosage information can be found in the accompanying Prescribing Information. Manufactured by Strides Pharma, Inc. and marketed by GSMS, Incorporated in Camarillo, CA. This information is valid as of revision 09/22.*

FDA Label Image

51407-657-01 (REV 09-22.jpg)

This is a description of Nateglinide tablets, USP, with 120mg of the active ingredient in each tablet. The medication is only available with a prescription, and it should be stored in a tightly-sealed container away from children, with an acceptable temperature range of 15°C to 30°C. The manufacturer is Strides Pharma, Inc. and it is marketed by GSMS, Incorporated in Camarillo, California. Please consult with the accompanying prescribing information for proper dosage instructions.*

FDA Label Image

Nateglinide Structural Formula (8ef82f54 6c76 4094 B7c2 5dc567e24c5b 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.